4UBI:XETRA:XETRA-UBS (Irl) ETF plc - MSCI USA Socially Responsible UCITS ETF (USD) A-acc (EUR)

ETF | Others |

Last Closing

USD 16.08

Change

-0.16 (-1.00)%

Market Cap

USD 0.37B

Volume

9.94K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-04-17 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

+0.21 (+0.42%)

USD 450.46B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

+0.08 (+0.51%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

+0.13 (+0.50%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

+0.27 (+0.99%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

-0.04 (-0.17%)

USD 157.79B
TM5:XETRA T-MOBILE US INC.DL-00001

-1.02 (-0.66%)

USD 126.93B
8R80:XETRA Amundi Index Solutions - Amund..

-0.56 (-0.40%)

USD 104.09B
JARI:XETRA Amundi Index Solutions - Amund..

-0.25 (-0.58%)

USD 101.29B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

+0.28 (+0.55%)

USD 85.64B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

-1.10 (-0.22%)

USD 80.38B

ETFs Containing 4UBI:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 5.72% 69% C- 68% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 5.72% 69% C- 68% D+
Trailing 12 Months  
Capital Gain 25.68% 87% B+ 86% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 25.68% 87% B+ 86% B+
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 6.33% 63% D 61% D-
Dividend Return 6.33% 61% D- 58% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 10.67% 59% D- 67% D+
Risk Adjusted Return 59.34% 79% B- 80% B-
Market Capitalization 0.37B 62% D 55% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike